Progression of Primary Angle Closure Suspects: a Systematic Review and Meta-analysis

Overview

Journal Eye (Lond)

Date 2025 Feb 5

PMID 39905214

Authors

Patrick Xiang Ji

Lauren Pickel

Michael Balas

David J Mathew

Affiliations

Soon will be listed here.

Abstract

This systematic review and meta-analysis examined the proportion of primary angle closure suspects (PACS) progressing to primary angle closure (PAC), acute angle closure (AAC), and primary angle closure glaucoma (PACG) and evaluated the impact of prophylactic laser peripheral iridotomy (LPI) on disease progression. A systematic search was performed on MEDLINE and EMBASE for studies published until November 2023 that reported on the proportion of PACS progressing to PAC. Using random-effects modelling, risk ratios and 95% confidence intervals estimated the proportion of progressing PACS between patients who received LPI versus those who did not. Two randomized-controlled-trials and three observational studies included a total of 1997 PACS patients. The weighted average age was 57.2 years with 74.7% females, and an average follow-up period of 6.2 years. Overall, 284 (14.2%) PACS patients progressed to either PAC (n = 258, 12.9%), AAC (n = 9, 0.5%), or PACG (n = 17, 0.9%). Patients receiving LPI displayed a 2.49-fold decrease in the risk of progression to PAC (RR: 2.49; 95% CI = 1.50-4.07; p < 0.001; NNT = 15), suggesting that there is a higher risk of disease progression without LPI. However, for the progressions to AAC and PACG, statistical significance was not reached. The present study provides valuable insights to the proportion of PACS who showed disease progression and underscores the potential benefit of prophylactic LPI in reducing the risk of angle closure disease progression. However, this study also addresses the issues surrounding the lack of demonstrated clinical efficacy for this intervention, thus advocating for a balanced approach in clinical decision-making.

References

Sun X, Dai Y, Chen Y, Yu D, Cringle S, Chen J . Primary angle closure glaucoma: What we know and what we don't know. Prog Retin Eye Res. 2017; 57:26-45. DOI: 10.1016/j.preteyeres.2016.12.003. View

Murgoitio-Esandi J, Xu B, Song B, Zhou Q, Oberai A . A Mechanistic Model of Aqueous Humor Flow to Study Effects of Angle Closure on Intraocular Pressure. Transl Vis Sci Technol. 2023; 12(1):16. PMC: 9838584. DOI: 10.1167/tvst.12.1.16. View

Radhakrishnan S, Chen P, Junk A, Nouri-Mahdavi K, Chen T . Laser Peripheral Iridotomy in Primary Angle Closure: A Report by the American Academy of Ophthalmology. Ophthalmology. 2018; 125(7):1110-1120. DOI: 10.1016/j.ophtha.2018.01.015. View

Parajuli S, Sharma S, Adhikary R, Malla D, Shrestha R, Shakya P . Comparative study of the effects of laser peripheral iridotomy and cataract surgery on anterior chamber angle parameters in primary angle closure suspect patients. BMJ Open Ophthalmol. 2023; 8(1). PMC: 10450083. DOI: 10.1136/bmjophth-2023-001339. View

Ong A, McCann P, Perera S, Lim F, Ng S, Friedman D . Lens extraction versus laser peripheral iridotomy for acute primary angle closure. Cochrane Database Syst Rev. 2023; 3:CD015116. PMC: 9994579. DOI: 10.1002/14651858.CD015116.pub2. View

Mou D, Liang Y, Fan S, Peng Y, Wang N, Thomas R . Progression rate to primary angle closure following laser peripheral iridotomy in primary angle-closure suspects: a randomised study. Int J Ophthalmol. 2021; 14(8):1179-1184. PMC: 8342280. DOI: 10.18240/ijo.2021.08.07. View

Bobrow J . Factors influencing cataract formation after Nd:YAG laser peripheral iridotomy. Trans Am Ophthalmol Soc. 2009; 106:93-7. PMC: 2646425. View

Lim L, Husain R, Gazzard G, Seah S, Aung T . Cataract progression after prophylactic laser peripheral iridotomy: potential implications for the prevention of glaucoma blindness. Ophthalmology. 2005; 112(8):1355-9. DOI: 10.1016/j.ophtha.2005.02.026. View

Chang D, Jiang Y, Kim J, Huang S, Munoz B, Aung T . Cataract progression after Nd:YAG laser iridotomy in primary angle-closure suspect eyes. Br J Ophthalmol. 2022; 107(9):1264-1268. DOI: 10.1136/bjophthalmol-2021-320929. View

10.

Vijaya L, Asokan R, Panday M, George R . Is prophylactic laser peripheral iridotomy for primary angle closure suspects a risk factor for cataract progression? The Chennai Eye Disease Incidence Study. Br J Ophthalmol. 2016; 101(5):665-670. DOI: 10.1136/bjophthalmol-2016-308733. View

11.

Lee T, Yuxin Ng J, Nongpiur M, Tan W, Aung T, Perera S . Intraocular pressure spikes after a sequential laser peripheral iridotomy for angle closure. J Glaucoma. 2013; 23(9):644-8. DOI: 10.1097/IJG.0b013e318285fdaa. View

12.

Husain R, Gazzard G, Aung T, Chen Y, Padmanabhan V, Oen F . Initial management of acute primary angle closure: a randomized trial comparing phacoemulsification with laser peripheral iridotomy. Ophthalmology. 2012; 119(11):2274-81. DOI: 10.1016/j.ophtha.2012.06.015. View

13.

Lam D, Leung D, Tham C, Li F, Kwong Y, Chiu T . Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. Ophthalmology. 2008; 115(7):1134-40. DOI: 10.1016/j.ophtha.2007.10.033. View

14.

Guyatt G, Oxman A, Kunz R, Falck-Ytter Y, Vist G, Liberati A . Going from evidence to recommendations. BMJ. 2008; 336(7652):1049-51. PMC: 2376019. DOI: 10.1136/bmj.39493.646875.AE. View

15.

Sterne J, Savovic J, Page M, Elbers R, Blencowe N, Boutron I . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898. DOI: 10.1136/bmj.l4898. View

16.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

17.

Wan X, Wang W, Liu J, Tong T . Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014; 14:135. PMC: 4383202. DOI: 10.1186/1471-2288-14-135. View

18.

Foster P, Buhrmann R, Quigley H, Johnson G . The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002; 86(2):238-42. PMC: 1771026. DOI: 10.1136/bjo.86.2.238. View

19.

Tarongoy P, Ho C, Walton D . Angle-closure glaucoma: the role of the lens in the pathogenesis, prevention, and treatment. Surv Ophthalmol. 2009; 54(2):211-25. DOI: 10.1016/j.survophthal.2008.12.002. View

20.

Salimi A, Fanous A, Watt H, Abu-Nada M, Wang A, Harasymowycz P . Prevalence of zonulopathy in primary angle closure disease. Clin Exp Ophthalmol. 2021; 49(9):1018-1026. PMC: 9293109. DOI: 10.1111/ceo.13983. View